results: at least one gastrointestinal symptom was reported by 619 of 1620 (38.2%) persons in the olestra group and 576 of 1561 (36.9%) controls (difference, 1.3 percentage points [95% ci, -3.6 to 6.2 percentage points]; p = 0.60).